首页> 外国专利> EYE-SELECTIVE BETA-BLOCKING DRUG AS ANTIGLAUCOMA DRUG

EYE-SELECTIVE BETA-BLOCKING DRUG AS ANTIGLAUCOMA DRUG

机译:选择性眼阻滞药物作为抗青光眼药物

摘要

In accordance with the present invention, disclosed herein are compounds of the formula CHEM wherein R is hydrogen, straight or branched loweralkyl, cycloalkyl, amino, loweralkoxy or acylamino, and R1 is straight or branched loweralkyl, amino, cyclohexyl, morpholino, piperidino, tetrahydrofuranyl, dihydrofuranyl, furanyl, tetrahydropyranyl, dioxolanyl, 2,2-dimethyl dioxolanyl, dioxanyl, pyrrolidinyl, tetrahydrooxazolyl, and dihydrooxazolyl, R2 is hydrogen or -COR3 wherein R3 is straight or branched loweralkyl, provided, however, when R1 is loweralkyl or cyclohexyl, R2 is not hydrogen, and pharmaceutically acceptable salts thereof. The compounds are useful in the treatment of glaucoma.
机译:根据本发明,本文公开了式的化合物,其中R为氢,直链或支链的低级烷基,环烷基,氨基,低级烷氧基或酰基氨基,R1为直链或支链的低级烷基,氨基,环己基,吗啉代,哌啶子基。 ,四氢呋喃基,二氢呋喃基,呋喃基,四氢吡喃基,二氧戊环基,2,2-二甲基二氧戊环基,二氧杂烷基,吡咯烷基,四氢恶唑基和二氢恶唑基,但是,当R1为直链或支链的低级烷基时,R2为氢或-COR3,其中R3为直链或支链的低级烷基。环己基,R 2不是氢,及其药学上可接受的盐。该化合物可用于治疗青光眼。

著录项

  • 公开/公告号JPH02243664A

    专利类型

  • 公开/公告日1990-09-27

    原文格式PDF

  • 申请/专利权人 E I DU PONT DE NEMOURS & CO;

    申请/专利号JP19890324204

  • 申请日1989-12-15

  • 分类号A61K31/24;A61K31/245;A61K31/34;A61K31/341;A61K31/35;A61K31/351;A61K31/535;A61K31/5375;A61P25/02;A61P27/02;A61P27/06;C07C233/36;C07C233/37;C07C233/40;C07C233/62;C07C233/78;C07C235/50;C07C235/60;C07D295/18;C07D295/215;C07D307/24;C07D307/68;C07D309/08;

  • 国家 JP

  • 入库时间 2022-08-22 06:23:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号